| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 0 | 50.838 | - | - | - |
| Total Income - EUR | - | - | - | - | 0 | 503 | 50.353 | - | - | - |
| Total Expenses - EUR | - | - | - | - | 6.154 | 72.677 | 35.388 | - | - | - |
| Gross Profit/Loss - EUR | - | - | - | - | -6.154 | -72.174 | 14.965 | - | - | - |
| Net Profit/Loss - EUR | - | - | - | - | -6.154 | -72.189 | 13.784 | - | - | - |
| Employees | - | - | - | - | 0 | 0 | 1 | - | - | - |
Check the financial reports for the company - Canepa Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 10.069 | 27.706 | - | - | - |
| Current Assets | - | - | - | - | 210 | 59.893 | 44.552 | - | - | - |
| Inventories | - | - | - | - | 0 | 52.244 | 30.005 | - | - | - |
| Receivables | - | - | - | - | 32 | 6.214 | 11.792 | - | - | - |
| Cash | - | - | - | - | 178 | 1.434 | 2.755 | - | - | - |
| Shareholders Funds | - | - | - | - | -6.112 | -78.185 | -63.016 | - | - | - |
| Social Capital | - | - | - | - | 42 | 41 | 81 | - | - | - |
| Debts | - | - | - | - | 6.322 | 148.146 | 135.274 | - | - | - |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "116 - 116" | |||||||||
| CAEN Financial Year |
116
|
|||||||||
Comments - Canepa Pharma S.r.l.